UBS Maintains a 'Buy' on Bruker (BRKR); Pieces of the Puzzle Fitting Together
Tweet Send to a FriendGet Alerts BRKR Hot Sheet
Price: $16.79 --0%
Rating Summary:
12 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 17 | New: 21
Rating Summary:
12 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 17 | New: 21
Trade BRKR Now!
UBS maintains a 'Buy' on Bruker (NASDAQ: BRKR) price target raised $1 to $19.
Analyst, Daniel Arias, said, "BRKR saw improved customer sentiment vs. 4Q & broad-based demand across the portfolio, which drove growth and grew backlog. Importantly, mgmt noted that the top-line is being impacted more by technology & secular trends than macro/budget fluctuation...Going forward, BRKR’s favorable position w/i several end mkts & continuing operational improvement should enable strong sales & EPS growth in both ’12 and ’13, and we look for shares to outperform."
For an analyst ratings summary and ratings history on Bruker click here. For more ratings news on Bruker click here.
Shares of Bruker closed at $16.07 yesterday, with a 52 week range of $11.48-$21.30.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Daniel Arias, said, "BRKR saw improved customer sentiment vs. 4Q & broad-based demand across the portfolio, which drove growth and grew backlog. Importantly, mgmt noted that the top-line is being impacted more by technology & secular trends than macro/budget fluctuation...Going forward, BRKR’s favorable position w/i several end mkts & continuing operational improvement should enable strong sales & EPS growth in both ’12 and ’13, and we look for shares to outperform."
For an analyst ratings summary and ratings history on Bruker click here. For more ratings news on Bruker click here.
Shares of Bruker closed at $16.07 yesterday, with a 52 week range of $11.48-$21.30.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Goldman Sachs Upgrades Tanger Factory Outlet Centers (SKT) to Neutral
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
UBS
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
